Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: A retrospective matched cohort study from Massachusetts

J Am Acad Dermatol. 2022 Jan;86(1):252-255. doi: 10.1016/j.jaad.2021.08.065. Epub 2021 Sep 10.
No abstract available

Keywords: COVID-19; IL-12/22; IL-17A; IL-4A; TNF; atopic dermatitis; autoimmune diseases; biologics; psoriasis; systemic immunosuppression; systemic lupus erythematosus.

MeSH terms

  • Biological Products* / adverse effects
  • COVID-19* / epidemiology
  • COVID-19* / mortality
  • Humans
  • Immunosuppressive Agents* / adverse effects
  • Massachusetts / epidemiology
  • Retrospective Studies


  • Biological Products
  • Immunosuppressive Agents